Project

Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease

Ongoing - recruitment closed · 2022 until 2023

Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Ongoing - recruitment closed
Start Date
2022
End Date
2023
Financing
Self Financed, KSSG
Partner
Inselspital Bern
Labels
esophagus cancer
Brief description/objective

This is a national multi-center cohort confirmatory study which is designed as a prospective
observational trial combined with retrospective data collection. Prospective data are collected
through a patient questionnaire and assessment of blood samples taken at inclusion.
Retrospective data are collected manually from patient medical records. The study design is
based on the CLARITY study.